AMAG PHARMACEUTICALS INC's ticker is and the CUSIP is 00163UAA4. A total of 32 filers reported holding AMAG PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $5,166,000 | -22.7% | 4,724,000 | 0.0% | 0.20% | -21.1% |
| Q4 2016 | $6,686,000 | +25.1% | 4,724,000 | -0.0% | 0.25% | +32.1% |
| Q3 2016 | $5,346,000 | +1.0% | 4,726,000 | -1.0% | 0.19% | -1.0% |
| Q2 2016 | $5,293,000 | +2.2% | 4,774,000 | 0.0% | 0.19% | +13.6% |
| Q1 2016 | $5,179,000 | -13.1% | 4,774,000 | +1.1% | 0.17% | -12.9% |
| Q4 2015 | $5,958,000 | +146.9% | 4,724,000 | +214.9% | 0.19% | +173.2% |
| Q3 2015 | $2,413,000 | -37.8% | 1,500,000 | 0.0% | 0.07% | -28.3% |
| Q2 2015 | $3,879,000 | -62.7% | 1,500,000 | -70.0% | 0.10% | -62.1% |
| Q1 2015 | $10,392,000 | +24.3% | 5,000,000 | 0.0% | 0.26% | +29.2% |
| Q4 2014 | $8,362,000 | +25.0% | 5,000,000 | 0.0% | 0.20% | +19.5% |
| Q3 2014 | $6,688,000 | +26.0% | 5,000,000 | 0.0% | 0.17% | +31.0% |
| Q2 2014 | $5,309,000 | +4.1% | 5,000,000 | 0.0% | 0.13% | +3.2% |
| Q1 2014 | $5,100,000 | – | 5,000,000 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| STEELHEAD PARTNERS LLC | 22,000,000 | $24,050,000 | 2.14% |
| LINDEN ADVISORS LP | 35,213,000 | $38,458,000 | 1.43% |
| Bruce & Co., Inc. | 5,500,000 | $5,775,000 | 1.38% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 11,003,000 | $12,059,000 | 1.23% |
| MACKAY SHIELDS LLC | 16,877,000 | $18,442,000 | 0.84% |
| ANGELO GORDON & CO., L.P. | 11,000,000 | $11,983,000 | 0.73% |
| IRON Financial LLC | 535,000 | $585,000 | 0.42% |
| WOLVERINE ASSET MANAGEMENT LLC | 18,400,000 | $20,111,000 | 0.31% |
| Sonora Investment Management, LLC | 1,430,000 | $1,556,598,000 | 0.30% |
| SSI INVESTMENT MANAGEMENT LLC | 2,830,000 | $3,084,000 | 0.28% |